[조사자료] 글로벌 항감염제 시장 (2023-2030) : 항바이러스제, 항진균제

■ 영문 제목 : Anti-infective Agents Market Size, Share & Trends Analysis Report By Type/Drug Class (Antivirals, Antifungals), By Route Of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2023 - 2030
	■ 상품코드 : GRV23NOV037 ■ 조사/발행회사 : Grand View Research ■ 발행일 : 2023년 9월 ■ 페이지수 : 120 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 (납기:3일) ■ 조사대상 지역 : 세계 ■ 산업 분야 : 의약품

■ 판매가격 / 옵션 (부가세 10% 별도)

Single User (1인 열람용)	USD5,950 ⇒환산￦8,032,500	견적의뢰/주문/질문
Multi User (5인 열람용)	USD6,950 ⇒환산￦9,382,500	견적의뢰/주문/질문
Global/corporate License (기업 열람용)	USD8,950 ⇒환산￦12,082,500	견적의뢰/구입/질문

※가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.

글로벌 항감염제 시장의 성장과 동향
Grand View Research사의 최신 보고서에 따르면, 세계의 항감염제 시장 규모는 2023년부터 2030년까지 연평균 1. 2%의 성장률을 기록하여 2030년까지 1,506억 달러에 달할 것으로 예상됩니다. 전염병의 증가는 지난 수십 년 동안 지역사회의 행동 패턴이 크게 변화한 것을 반영합니다. 사회 변화와 의료진과 환자의 인식이 높아지면서 성장을 촉진하고 있습니다.

세계보건기구(WHO)나 질병대책예방센터(CDC) 등의 조직은 감염증이 초래하는 치명적인 영향과 조기 치료의 중요성에 관한 사람들의 의식을 넓히기 위해 적극적으로 노력하고 있습니다. CDC는 브라질, 중국, 나이지리아, 인도 등 개발도상국에서 전염병에 대한 인식을 넓히고 치료를 강화하기 위해 국가보건부(NHM)와 협력하고 있습니다.

그러나 효능과 효과를 높인 새로운 치료제의 도입과 2018년 시중에서 획득한 세균성 폐렴(CABP) 치료제로 오마다사이클린이 상용화되는 등 파이프라인 제품의 상용화가 항감염제 시장의 성장을 촉진할 것으로 예상됩니다.

항감염제 시장 보고서 주요 내용

- HIV 치료제인 비클리비록과 같은 새로운 강력한 항바이러스제와 관련된 높은 가격으로 인해 2022년 시장 점유율이 53. 2%로 가장 큰 부문이 될 것으로 추정됩니다.

- 항균제 부문은 예측 기간 동안 가장 빠른 CAGR 4. 2%를 기록할 것으로 예상됩니다. 시판 중인 항균제의 처방과 접근성이 높아짐에 따라 항균제 부문이 더욱 성장할 것으로 예상됩니다.

- 생명을 위협하는 심각한 감염증의 치료와 예방을 위한 복합제 개발은 항감염제 사용을 촉진할 것으로 예상됩니다. 예를 들어, 길리어드 사이언스(Gilead Sciences, Inc.)는 2012년 레트로바이러스 치료 경험이 없는 HIV 환자 치료에 사용되는 4제(코비시스타트, 엘비테그라비르, 엠트리시타빈, 테노포비르 디소프록실푸마르산염) 복합제인 스트리빌드(Stryvild)를 출시했습니다.

- 신제품 개발과 강력한 제품 파이프라인의 존재로 인해 2022년에는 경구 투여 경로가 가장 큰 세그먼트가 될 것으로 예상됩니다.

- 2022년에는 병원 약국이 28. 8%의 매출 점유율로 시장을 장악할 것으로 예상되며, 예측 기간 동안 전자 상거래가 가장 빠르게 성장할 것으로 보입니다.

- 2022년 북미 지역이 전체 매출의 37.0%로 가장 큰 점유율을 차지하며 세계 시장을 주도할 것으로 보입니다. 소아 및 성인 모두에서 병원 내 감염을 포함한 감염성 질환의 높은 유병률과 이로 인한 항생제 과다 사용, 비처방 항감염제 접근성 증가가 주요 요인으로 작용할 것으로 보입니다.

- 아시아 태평양 지역은 새로운 약물에 대한 높은 미충족 수요, 의료 인프라의 급속한 개선, 의료진과 환자의 인식 증가로 인해 가장 빠르게 성장하는 지역 중 하나입니다.

- 효과적인 질병 관리를 위해서는 신제품 개발, M&A, 공동 개발, 사업 확장 등 다양한 장기 전략이 필요합니다. 예를 들어, 2015년 ReViral은 웰컴 트러스트(Wellcome Trust.)로부터 RV521 의약품 개발을 위해 2,100만 달러의 자금을 지원받았습니다.

■ 보고서 개요

Chapter 1. 조사 방법 및 범위
Chapter 2. 개요
Chapter 3. 세계의 항감염제 시장 변수/동향/범위
Chapter 4. 세계의 항감염제 시장 : 종류/약물 종류별 예측 및 동향 분석
Chapter 5. 세계의 항감염제 시장 : 투여 경로별 예측 및 동향 분석
Chapter 6. 세계의 항감염제 시장 : 유통 채널별 예측 및 동향 분석
Chapter 7. 세계의 항감염제 시장 : 지역별 예측 및 동향 분석
Chapter 8. 경쟁 현황

■ 보고서 목차

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Type
1.1.2. Route of Administration
1.1.3. Distribution Channel
1.1.4. Regional scope
1.1.5. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary route of administrations
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Type outlook
2.2.2. Route of administration outlook
2.2.3. Distribution channel outlook
2.2.4. Regional outlook
2.3. Competitive Insights
Chapter 3. Anti-Infective Agents Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market Driver Analysis
3.3.2. Market Restraint Analysis
3.4. Anti-Infective Agents Market Analysis Tools
3.4.1. Industry Analysis – Porter’s
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic Landscape
Chapter 4. Anti-Infective Agents: Type/Drug Class Estimates & Trend Analysis
4.1. Anti-Infective Agents Market: Key Takeaways
4.2. Anti-Infective Agents Market: Movement & Market Share Analysis, 2022 & 2030
4.3. Antibacterials
4.3.1. Antibacterials market estimates and forecasts, 2018 to 2030 (USD Billion)
4.3.2. Antibacterials drug class market estimates and forecasts, 2018 to 2030 (USD Billion)
4.3.2.1. Cephalosporins
4.3.2.1.1 Cephalosporins market estimates and forecasts, 2018 to 2030 (USD Billion)
4.3.2.2. Penicillin
4.3.2.2.1 Penicillin market estimates and forecasts, 2018 to 2030 (USD Billion)
4.3.2.3. Fluoroquinolones
4.3.2.2.2 Fluoroquinolones market estimates and forecasts, 2018 to 2030 (USD Billion)
4.3.2.3 Macrolides
4.3.2.3.1 Macrolides market estimates and forecasts, 2018 to 2030 (USD Billion)
4.3.2.4 Carbapenem
4.3.2.4.1 Carbapenem market estimates and forecasts, 2018 to 2030 (USD Billion)
4.3.2.5 Others
4.3.2.5.1 Others market estimates and forecasts, 2018 to 2030 (USD Billion)
4.4. Antivirals
4.4.1. Antivirals market estimates and forecasts, 2018 to 2030 (USD Billion)
4.5. Antifungals
4.5.1. Antifungals market estimates and forecasts, 2018 to 2030 (USD Billion)
4.5.2. Antifungals drug class market estimates and forecasts, 2018 to 2030 (USD Billion)
4.5.2.1. Azoles
4.5.2.1.2 Azoles market estimates and forecasts, 2018 to 2030 (USD Billion)
4.5.2.2. Echinocandins
4.5.2.2.3 Echinocandins market estimates and forecasts, 2018 to 2030 (USD Billion)
4.5.2.3. Polyenes
4.5.2.2.4 Polyenes market estimates and forecasts, 2018 to 2030 (USD Billion)
4.5.2.3 Others
4.5.2.3.1 Others market estimates and forecasts, 2018 to 2030 (USD Billion)
Chapter 5. Anti-Infective Agents Market: Route of Administration Estimates & Trend Analysis
5.1. Anti-Infective Agents Market: Key Takeaways
5.2. Anti-Infective Agents Market: Movement & Market Share Analysis, 2022 & 2030
5.3. Topical
5.3.1. Topical market estimates and forecasts, 2018 to 2030 (USD Billion)
5.4. Oral
5.4.1. Oral market estimates and forecasts, 2018 to 2030 (USD Billion)
5.5. IV
5.5.1. IV market estimates and forecasts, 2018 to 2030 (USD Billion)
5.6. Others
5.6.1. Others market estimates and forecasts, 2018 to 2030 (USD Billion)
Chapter 6. Anti-Infective Agents Market: Distribution Channel Estimates & Trend Analysis
6.1. Anti-Infective Agents Market: Key Takeaways
6.2. Anti-Infective Agents Market: Movement & Market Share Analysis, 2022 & 2030
6.3. Hospital Pharmacies
6.3.1. Hospital pharmacies market estimates and forecasts, 2018 to 2030 (USD Billion)
6.4. Retail Pharmacies
6.4.1. Retail pharmacies market estimates and forecasts, 2018 to 2030 (USD Billion)
6.5. Specialty Pharmacies
6.5.1. Specialty pharmacies market estimates and forecasts, 2018 to 2030 (USD Billion)
6.6. E-Commerce
6.6.1. Specialty pharmacies market estimates and forecasts, 2018 to 2030 (USD Billion)
6.7. Others
6.7.1. Other market estimates and forecasts, 2018 to 2030 (USD Billion)
Chapter 7. Anti-Infective Agents Market: Regional Estimates & Trend Analysis
7.1. Regional Outlook
7.2. Anti-Infective Agents Market by Region: Key Takeaways
7.3. North America
7.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
7.3.2. U.S.
7.3.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
7.3.3. Canada
7.3.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
7.4. Europe
7.4.1. UK
7.4.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
7.4.2. Germany
7.4.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
7.4.3. France
7.4.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
7.4.4. Italy
7.4.4.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
7.4.5. Spain
7.4.5.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
7.4.6. Sweden
7.4.6.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
7.4.7. Norway
7.4.7.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
7.4.8. Denmark
7.4.8.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
7.5. Asia Pacific
7.5.1. Japan
7.5.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
7.5.2. China
7.5.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
7.5.3. India
7.5.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
7.5.4. Australia
7.5.4.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
7.5.5. Thailand
7.5.5.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
7.5.6. South Korea
7.5.6.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
7.6. Latin America
7.6.1. Brazil
7.6.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
7.6.2. Mexico
7.6.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
7.6.3. Argentina
7.6.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
7.7. MEA
7.7.1. South Africa
7.7.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
7.7.2. Saudi Arabia
7.7.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
7.7.3. UAE
7.7.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
7.7.4. Kuwait
7.7.4.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Market Participant Categorization
8.2.1. Pfizer Inc.
8.2.1.1. Company overview
8.2.1.2. Financial performance
8.2.1.3. Product benchmarking
8.2.1.4. Strategic initiatives
8.2.2. Abbott.
8.2.2.1. Company overview
8.2.2.2. Financial performance
8.2.2.3. Product benchmarking
8.2.2.4. Strategic initiatives
8.2.3. Gilead Sciences, Inc.
8.2.3.1. Company overview
8.2.3.2. Financial performance
8.2.3.3. Product benchmarking
8.2.3.4. Strategic initiatives
8.2.4. Bristol-Myers Squibb Company
8.2.4.1. Company overview
8.2.4.2. Financial performance
8.2.4.3. Product benchmarking
8.2.4.4. Strategic initiatives
8.2.5. Merck & Co., Inc.
8.2.5.1. Company overview
8.2.5.2. Financial performance
8.2.5.3. Product benchmarking
8.2.5.4. Strategic initiatives
8.2.6. Sandoz International GmbH
8.2.6.1. Company overview
8.2.6.2. Financial performance
8.2.6.3. Product benchmarking
8.2.6.4. Strategic initiatives
8.2.7. B. Braun SE
8.2.7.1. Company overview
8.2.7.2. Financial performance
8.2.7.3. Product benchmarking
8.2.7.4. Strategic initiatives
8.2.8. Xellia Pharmaceuticals
8.2.8.1. Company overview
8.2.8.2. Financial performance
8.2.8.3. Product benchmarking
8.2.8.4. Strategic initiatives
8.2.9. Mankind Pharma
8.2.9.1. Company overview
8.2.9.2. Financial performance
8.2.9.3. Product benchmarking
8.2.9.4. Strategic initiatives
8.2.10. Bayer AG
8.2.10.1. Company overview
8.2.10.2. Financial performance
8.2.10.3. Product benchmarking
8.2.10.4. Strategic initiatives
8.2.11. AstraZeneca
8.2.11.1. Company overview
8.2.11.2. Financial performance
8.2.11.3. Product benchmarking
8.2.11.4. Strategic initiatives
8.2.12. Boehringer Ingelheim International GmbH.
8.2.12.1. Company overview
8.2.12.2. Financial performance
8.2.12.3. Product benchmarking
8.2.12.4. Strategic initiatives

List of Tables

Table 1 List of Abbreviations
Table 2 North America anti-infective agents market, by type, 2018 - 2030 (USD Billion)
Table 3 North America anti-infective agents market, by route of administration, 2018 - 2030 (USD Billion)
Table 4 North America anti-infective agents market, by distribution channel, 2018 - 2030 (USD Billion)
Table 5 North America anti-infective agents market, by region, 2018 - 2030 (USD Billion)
Table 6 U.S. anti-infective agents market, by type, 2018 - 2030 (USD Billion)
Table 7 U.S. anti-infective agents market, by route of administration, 2018 - 2030 (USD Billion)
Table 8 U.S. anti-infective agents market, by distribution channel, 2018 - 2030 (USD Billion)
Table 9 Canada anti-infective agents market, by type, 2018 - 2030 (USD Billion)
Table 10 Canada anti-infective agents market, by route of administration, 2018 - 2030 (USD Billion)
Table 11 Canada anti-infective agents market, by distribution channel, 2018 - 2030 (USD Billion)
Table 12 Europe anti-infective agents market, by type, 2018 - 2030 (USD Billion)
Table 13 Europe anti-infective agents market, by route of administration, 2018 - 2030 (USD Billion)
Table 14 Europe anti-infective agents market, by distribution channel, 2018 - 2030 (USD Billion)
Table 15 Europe anti-infective agents market, by region, 2018 - 2030 (USD Billion)
Table 16 Germany anti-infective agents market, by type, 2018 - 2030 (USD Billion)
Table 17 Germany anti-infective agents market, by route of administration, 2018 - 2030 (USD Billion)
Table 18 Germany anti-infective agents market, by distribution channel, 2018 - 2030 (USD Billion)
Table 19 UK anti-infective agents market, by type, 2018 - 2030 (USD Billion)
Table 20 UK anti-infective agents market, by route of administration, 2018 - 2030 (USD Billion)
Table 21 UK anti-infective agents market, by distribution channel, 2018 - 2030 (USD Billion)
Table 22 France anti-infective agents market, by type, 2018 - 2030 (USD Billion)
Table 23 France anti-infective agents market, by route of administration, 2018 - 2030 (USD Billion)
Table 24 France anti-infective agents market, by distribution channel, 2018 - 2030 (USD Billion)
Table 25 Italy anti-infective agents market, by type, 2018 - 2030 (USD Billion)
Table 26 Italy anti-infective agents market, by route of administration, 2018 - 2030 (USD Billion)
Table 27 Italy anti-infective agents market, by distribution channel, 2018 - 2030 (USD Billion)
Table 28 Spain anti-infective agents market, by type, 2018 - 2030 (USD Billion)
Table 29 Spain anti-infective agents market, by route of administration, 2018 - 2030 (USD Billion)
Table 30 Spain anti-infective agents market, by distribution channel, 2018 - 2030 (USD Billion)
Table 31 Sweden anti-infective agents market, by type, 2018 - 2030 (USD Billion)
Table 32 Sweden anti-infective agents market, by route of administration, 2018 - 2030 (USD Billion)
Table 33 Sweden anti-infective agents market, by distribution channel, 2018 - 2030 (USD Billion)
Table 34 Norway anti-infective agents market, by type, 2018 - 2030 (USD Billion)
Table 35 Norway anti-infective agents market, by route of administration, 2018 - 2030 (USD Billion)
Table 36 Norway anti-infective agents market, by distribution channel, 2018 - 2030 (USD Billion)
Table 37 Denmark anti-infective agents market, by type, 2018 - 2030 (USD Billion)
Table 38 Denmark anti-infective agents market, by route of administration, 2018 - 2030 (USD Billion)
Table 39 Denmark anti-infective agents market, by distribution channel, 2018 - 2030 (USD Billion)
Table 40 Asia Pacific anti-infective agents market, by type, 2018 - 2030 (USD Billion)
Table 41 Asia Pacific anti-infective agents market, by route of administration, 2018 - 2030 (USD Billion)
Table 42 Asia Pacific anti-infective agents market, by distribution channel, 2018 - 2030 (USD Billion)
Table 43 Asia Pacific anti-infective agents market, by region, 2018 - 2030 (USD Billion)
Table 44 Japan anti-infective agents market, by type, 2018 - 2030 (USD Billion)
Table 45 Japan anti-infective agents market, by route of administration, 2018 - 2030 (USD Billion)
Table 46 Japan anti-infective agents market, by distribution channel, 2018 - 2030 (USD Billion)
Table 47 China anti-infective agents market, by type, 2018 - 2030 (USD Billion)
Table 48 China anti-infective agents market, by route of administration, 2018 - 2030 (USD Billion)
Table 49 China anti-infective agents market, by distribution channel, 2018 - 2030 (USD Billion)
Table 50 India anti-infective agents market, by type, 2018 - 2030 (USD Billion)
Table 51 India anti-infective agents market, by route of administration, 2018 - 2030 (USD Billion)
Table 52 India anti-infective agents market, by distribution channel, 2018 - 2030 (USD Billion)
Table 53 Australia anti-infective agents market, by type, 2018 - 2030 (USD Billion)
Table 54 Australia anti-infective agents market, by route of administration, 2018 - 2030 (USD Billion)
Table 55 Australia anti-infective agents market, by distribution channel, 2018 - 2030 (USD Billion)
Table 56 Thailand anti-infective agents market, by type, 2018 - 2030 (USD Billion)
Table 57 Thailand anti-infective agents market, by route of administration, 2018 - 2030 (USD Billion)
Table 58 Thailand anti-infective agents market, by distribution channel, 2018 - 2030 (USD Billion)
Table 59 South Korea anti-infective agents market, by type, 2018 - 2030 (USD Billion)
Table 60 South Korea anti-infective agents market, by route of administration, 2018 - 2030 (USD Billion)
Table 61 South Korea anti-infective agents market, by distribution channel, 2018 - 2030 (USD Billion)
Table 62 Latin America anti-infective agents market, by type, 2018 - 2030 (USD Billion)
Table 63 Latin America anti-infective agents market, by route of administration, 2018 - 2030 (USD Billion)
Table 64 Latin America anti-infective agents market, by distribution channel, 2018 - 2030 (USD Billion)
Table 65 Latin America anti-infective agents market, by region, 2018 - 2030 (USD Billion)
Table 66 Brazil anti-infective agents market, by type, 2018 - 2030 (USD Billion)
Table 67 Brazil anti-infective agents market, by route of administration, 2018 - 2030 (USD Billion)
Table 68 Brazil anti-infective agents market, by distribution channel, 2018 - 2030 (USD Billion)
Table 69 Mexico anti-infective agents market, by type, 2018 - 2030 (USD Billion)
Table 70 Mexico anti-infective agents market, by route of administration, 2018 - 2030 (USD Billion)
Table 71 Mexico anti-infective agents market, by distribution channel, 2018 - 2030 (USD Billion)
Table 72 Argentina anti-infective agents market, by type, 2018 - 2030 (USD Billion)
Table 73 Argentina anti-infective agents market, by route of administration, 2018 - 2030 (USD Billion)
Table 74 Argentina anti-infective agents market, by distribution channel, 2018 - 2030 (USD Billion)
Table 75 Middle East and Africa anti-infective agents market, by type, 2018 - 2030 (USD Billion)
Table 76 Middle East and Africa anti-infective agents market, by route of administration, 2018 - 2030 (USD Billion)
Table 77 Middle East and Africa anti-infective agents market, by distribution channel, 2018 - 2030 (USD Billion)
Table 78 Middle East and Africa anti-infective agents market, by region, 2018 - 2030 (USD Billion)
Table 79 South Africa anti-infective agents market, by type, 2018 - 2030 (USD Billion)
Table 80 South Africa anti-infective agents market, by route of administration, 2018 - 2030 (USD Billion)
Table 81 South Africa anti-infective agents market, by distribution channel, 2018 - 2030 (USD Billion)
Table 82 Saudi Arabia anti-infective agents market, by type, 2018 - 2030 (USD Billion)
Table 83 Saudi Arabia anti-infective agents market, by route of administration, 2018 - 2030 (USD Billion)
Table 84 Saudi Arabia anti-infective agents market, by distribution channel, 2018 - 2030 (USD Billion)
Table 85 UAE anti-infective agents market, by type, 2018 - 2030 (USD Billion)
Table 86 UAE anti-infective agents market, by route of administration, 2018 - 2030 (USD Billion)
Table 87 UAE anti-infective agents market, by distribution channel, 2018 - 2030 (USD Billion)
Table 88 Kuwait anti-infective agents market, by type, 2018 - 2030 (USD Billion)
Table 89 Kuwait anti-infective agents market, by route of administration, 2018 - 2030 (USD Billion)
Table 90 Kuwait anti-infective agents market, by distribution channel, 2018 - 2030 (USD Billion)

※본 조사보고서 [글로벌 항감염제 시장 (2023-2030) : 항바이러스제, 항진균제] (코드 : GRV23NOV037) 판매에 관한 면책사항을 반드시 확인하세요.

※본 조사보고서 [글로벌 항감염제 시장 (2023-2030) : 항바이러스제, 항진균제] 에 대해서 E메일 문의는 여기를 클릭하세요.

※당 사이트에 없는 보고서도 취급 가능한 경우가 많으니 문의 주세요!

[이하, 관련 보고서 소개]

글로벌 항바이러스제 시장 (2023-2030) : 브랜드, 제네릭
GRV23NOV002 / Grand View Research / 2023년 9월 / 글로벌 항바이러스제 시장의 성장과 동향 Grand View Research사의 최신 보고서에 따르면, 세계의 항바이러스제 시장 규모는 2023년부터 2030년까지 연평균 성장률 -1. 99%를 기록하며 2030년까지 620. 5억 달러에 달할 것으로 예상됩니다. 이러한...Chapter 1. 조사 방법 및 범위 Chapter 2. 개요 Chapter 3. 시장 변수/동향/범위 Chapter 4. 세계의 항바이러스제 시장 : 유형별 분석 Chapter 5. 세계의 항바이러스제 시장 : 약품 종류별 분석 Chapter 6. 세계의 항바이러스제 시장 : 유통 채널별 분석 Chapter 7. 세계의 항바이러스제 시장 : 용도별 분석 Chapter 8. 세계의...

글로벌 전염병 치료제 시장 (2023-2030) : HIV, 간염, 인플루엔자, 결핵, 말라리아, HPV
GRV23NOV149 / Grand View Research / 2023년 9월 / 글로벌 전염병 치료제 시장의 성장과 동향 Grand View Research사의 최신 보고서에 따르면, 세계의 전염병 치료제 시장 규모는 2023년부터 2030년까지 연평균 7. 1%의 성장률을 기록하여 2030년에는 1,152억 달러에 달할 것으로 예상됩니다....Chapter 1. 조사 방법 및 범위 Chapter 2. 개요 Chapter 3. 세계의 전염병 치료제 시장 변수/동향/범위 Chapter 4. 세계의 전염병 치료제 시장 : 질병 유형별 예측 및 동향 분석 Chapter 5. 세계의 감염증 치료제 시장 : 최종 용도별 예측 및 동향 분석 Chapter 6. 세계의 전염병 치료제 시장 : 지역별...

세계의 국소 상처 치료제 시장 2023-2030 : 크림, 젤, 스프레이, 기타
GRV24JNU033 / Grand View Research / 2023년 12월 / 글로벌 국소 상처 치료제 시장의 성장과 동향 Grand View Research, Inc.사의 최신 보고서에 따르면, 세계의 국소 상처 치료제 시장 규모는 2023년부터 2030년까지 연평균 8.1%의 성장률을 기록하며 2030년까지 28억 달러에 달할...1. 조사 방법 및 범위 2. 개요 3. 세계의 국소 상처 치료제 시장 변수, 동향, 범위 4. 세계의 국소 상처 치료제 시장 규모 : 제품별 예측 및 동향 분석 5. 세계의 국소 상처 치료제 시장 규모 : 용도별 예측 및 동향 분석 6. 세계의 국소 상처 치료제 시장 규모 :...

세계의 동결 건조 장치 시장 (2023~2030) : 벤치탑형 동결 건조 장치, 실험실용 동결 건조 장치
GRV23MA006 / Grand View Research / 2023년 1월 / 미국 Grand View Research (그랜드뷰리서치)는 세계의 동결 건조 장치 시장 규모가 2023년부터 2030년 사이에 연평균 9.1% 성장하여, 2030년에는 35억 달러에 달할 것으로 전망하고 있습니다. 본 조사 자료는 세계의 동결 건조...Freeze Drying Equipment Market Growth & Trends The global freeze drying equipment market size is anticipated to reach USD 3.50 billion by 2030, expanding at a CAGR of 9.1% from 2023 to 2030, according to a new report by Grand View Research, Inc. Rising demand for food preservation and increasing...

세계의 의약품 포장 장치 시장 (2023~2030) : 충전, 라벨링, 카토닝
GRV23MA009 / Grand View Research / 2023년 1월 / 미국 Grand View Research (그랜드뷰리서치)는 세계의 의약품 포장 장치 시장 규모가 2023년부터 2030년 사이에 연평균 5.5% 성장하여, 2030년에는 86.9억 달러에 달할 것으로 전망하고 있습니다. 본 조사 자료는 세계의 의약품 포장...Pharmaceutical Packaging Equipment Market Growth & Trends The global pharmaceutical packaging equipment market size is expected to reach USD 8.69 billion by 2030, expanding at 5.5% CAGR from 2023 to 2030, according to a new report by Grand View Research, Inc. The market is primarily driven by growing awareness regarding...